Aurobindo Pharma reported INR51.23B in Gross Profit on Sales for its fiscal quarter ending in December of 2025.





Gross Profit On Sales Change Date
Cipla INR 41.64B 6.31B Dec/2025
Divis Laboratories Ltd INR 16.59B 2.05B Dec/2025
Dr.Reddys Laboratories INR 51.37B 629M Dec/2025
Hindustan Unilever INR 81.13B 1.23B Dec/2025
Sun Pharmaceuticals INR 107.66B 2.05B Sep/2025
UPL INR 55.96B 1.01B Dec/2025